¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"potential abnormality of glucose tolerance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® glucose tolerance test ÇÑ±Û Æ÷µµ´ç°ßµõ°Ë»ç
¼³¸í   
  Æ÷µµ´ç°ßµõ °Ë»ç¶õ ´ç´¢º´ÀÇ Áø´Ü¿¡ »ç¿ëµÇ´Â °Ë»ç·Î ´çÀ» Ã¼³»¿¡ Åõ¿©ÇÏ°í ½Ã°£ º°·Î Ç÷¾×À» Ã¤ÃëÇÏ¿© Ç÷´çÀÇ ³óµµ¸¦ Àç¾î¼­ °íÇ÷´ç ¿©ºÎ¸¦ Á¶»çÇϴ °Ë»çÀÌ´Ù. ÁַΠ°æ±¸Æ÷µµ´ç°ßµõ°Ë»ç(oral glucose tolerance test)¸¦ ¸¹ÀÌ Çϴµ¥ À̰ÍÀº 10~16½Ã°£ÀÇ ±Ý½Ä ÈÄ¿¡ Ã¤Ç÷À» Çѹø Çѵڿ¡ µµ´ç 75gÀ» 250~300mLÀÇ ¹°¿¡ ³ì¿© 5ºÐ¿¡ °ÉÃļ­ ¸¶½Ã°Ô ÇÏ°í ¸Å½Ã°£ º°·Î Ã¤Ç÷À» ÇÏ¿© Ç÷´çÀÇ ³óµµ¸¦ Ã½Å©ÇÑ´Ù. °øº¹½Ã¿¡ Á¤¸Æ¿¡¼­ Ã¤Ç÷ÇÏ¿© ÃøÁ¤ÇÑ Ç÷´çÀÌ 140mg/dLÀÌ»óÀ̰ųª Æ÷µµ´ç°ßµõ °Ë»ç 2½Ã°£ÈÄÀÇ Ç÷´çÀÌ 200mg/dLÀÌ»óÀÏ °æ¿ì¿¡´Â ´ç´¢º´À¸·Î Áø´ÜÀ» ÇÑ´Ù. ±×·¯³ª ÀÌ °Ë»ç¸¦ ½Ç½ÃÇÒ °æ¿ì¿¡ ÁÖÀÇÇØ¾ß ÇÒ Á¡Àº °Ë»çÀü 3Àϰ£ ÇÏ·ç¿¡ 150gÀÌ»óÀǠź¼öÈ­¹°À» ¼·ÃëÇØ¾ß ÇѴٴ °Í°ú °Ë»çµµÁß¿¡ ¿îµ¿, Èí¿¬ µîÀ» ÇÏÁö ¾Ê¾Æ¾ß ÇѴٴ °ÍÀÌ´Ù. 
¿µ¹® tolerance ÇÑ±Û ³»¼º, °ßµõ
¼³¸í   
  1. ºñÁ¤»óÀûÀ¸·Î ´ë·®ÀÇ ¾à¹°¿¡ ´ëÇØ µ¶¼º¿µÇâÀ» ¹ÞÁö ¾Ê°í °ßµð¸ç ¶ÇÇÑ ÀÏÁ¤·®ÀÇ ¾à¹°ÀÇ Áö¼ÓÀûÀΠ»ç¿ë¿¡ ´ëÇØ¼­ È¿°úÀÇ °¨¼Ò¸¦ ³ªÅ¸³»´Â ´É·Â.
  
  2. ¸é¿ªÇÐÀûÀ¸·Î Ç׿øÆ¯ÀÌÀûÀΠ¹«¹ÝÀÀ »óÅÂ.
¿µ¹® glucose ÇÑ±Û Æ÷µµ´ç
¼³¸í   
  C6H12O6ÀÇ ±¸Á¶¸¦ °¡Áø ¹°Áú. Åº¼öÈ­¹° ´ë»çÀÇ ¸¶Áö¸· »ê¹°À̸砻ý¸íüÀÇ ÁÖ¿¡³ÊÁö¿øÀÌ´Ù. Æ¯È÷ ³úÀÇ °æ¿ì¿¡´Â ´Ù¸¥ °ÍÀ» ¿µ¾çºÐÀ¸·Î »ç¿ëÇÏÁö ¾Ê°í ´ÜÁö Æ÷µµ´ç¸¸À» ¿¡³ÊÁö¿øÀ¸·Î ÀÌ¿ëÇÑ´Ù. ¼¼Æ÷¿¡¼­ »ç¿ëÇÏ°í ³²Àº ¿©ºÐÀÇ Æ÷µµ´çÀº ±Û¸®ÄÚ°ÕÀ¸·Î ¹Ù²î¾î °£°ú ±ÙÀ°¿¡ ÀúÀåµÇ°í ±× ÀÌ»óÀº Áö¹æÁ¶Á÷¿¡¼­ ÁöÁú·Î º¯È¯µÇ¾î¼­ ÀúÀåµÈ´Ù.
¿µ¹® developmental abnormality ÇÑ±Û ¹ß´ÞÀÌ»ó
¼³¸í   
  ¹ß´Þ°úÁ¤, Áï ¼öÅ·κÎÅÍ »çÃá±â³ª ¾î¸¥ÀÌ µÇ¾î ¼º¼÷ÀÌ µÉ ¶§±îÁö »çÀÌ¿¡ ¾î´À ½Ã±â¿¡¼­ »ý±â´Â ÀÌ»óÀÌ´Ù. ±×·¯³ª Á¼Àº Àǹ̷δ ¼öźÎÅÍ Ãâ»ý±îÁöÀÇ ±â°£¿¡ »ý±ä ÀÌ»ó Áï ¼±ÃµÀÌ»óÀ» ÀǹÌÇÑ´Ù. ¼±ÃµÀÌ»ó(congenital abnormality)°ú µ¿ÀǾî.
¿µ¹® chromosome abnormality ÇÑ±Û ¿°»öüÀÌ»ó
¼³¸í   
  ¿°»öüÀÇ ¼ö³ª ±¸Á¶ÀÇ ÀÌ»ó. ÀÌ»óÀÌ »ý±ä ¼¼Æ÷³ª °³Ã¼´Â À¯ÀüÀûÀΠÀÌ»óÀ» ÀÏÀ¸ÄÑ »ç¶÷ÀÇ °æ¿ì, ´Ù¿î ÁõÈıº-ÅͳʠÁõÈıº µûÀ§ÀÇ ¿©·¯ °¡Áö ÇüÅ·Π³ªÅ¸³­´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glucose tolerance test
    ´çºÎÇϰ˻ç
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´ç³»¼º°Ë»ç
  • abnormality
    ÀÌ»ó, ºñÁ¤»ó
  • chromosomal abnormality
    ¿°»öüÀÌ»ó
  • developmental abnormality
    ¹ß´ÞÀÌ»ó
  • growth abnormality
    ¼ºÀåÀÌ»ó
  • motor abnormality
    ¿îµ¿ÀÌ»ó
  • metabolic abnormality
    ´ë»çÀÌ»ó
  • nailfold capillary abnormality
    ¼ÕÅéÁÖ¸§¸ð¼¼Ç÷°üÀÌ»ó
  • positional abnormality
    À§Ä¡ÀÌ»ó
  • blood glucose
    Ç÷´ç
  • blood glucose monitoring
    Ç÷´ç°¨½Ã
  • glucose
    Æ÷µµ´ç, ´ç±Û·çÄÚ¿À½º
  • glucose dehydrogenase
    Æ÷µµ´çÅ»¼ö¼ÒÈ¿¼Ò
  • glucose fermenter
    Æ÷µµ´ç¹ßÈ¿Åë
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glucose tolerance test
    ´çºÎÇϰ˻ç
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • tolerance
    ³»¼º, °ßµõ, Çã¿ë, °ü¿ë
  • abnormality
    ÀÌ»ó, ºñÁ¤»ó
  • chromosomal abnormality
    ¿°»öüÀÌ»ó
  • motor abnormality
    ¿îµ¿Àå¾Ö
  • positional abnormality
    À§Ä¡ÀÌ»ó
  • glucose
    Æ÷µµ´ç, ±Û·çÄÚ½º
  • urine glucose
    ¿ä´ç
  • glucose intolerance
    Æ÷µµ´ç¸ø°ßµõ(Áõ), ´çºÒ³»¼º
  • potential difference
    Àü¾ÐÂ÷, ÀüÀ§Â÷
  • potential gradient
    ÀüÀ§±â¿ï±â, ÀüÀ§Â÷
  • potential
    ÀüÀ§, °¡´É¼º, ÀáÀç·Â
  • action potential
    Ȱµ¿ÀüÀ§
  • auditory evoked potential
    µè±âÀ¯¹ßÀüÀ§, û°¢À¯¹ßÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cortisone glucose tolerance test
    ÄÚ¸£Æ¼¼ÕÆ÷µµ´çºÎÇϽÃÇè
  • glucose insulin tolerance test
    Æ÷µµ´çÀν¶¸°°ßµõ°Ë»ç
  • glucose tolerance test
    Æ÷µµ´ç°ßµõ°Ë»ç
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • abnormality
    ÀÌ»ó, ºñÁ¤»ó
  • chromosome abnormality
    ¿°»öüÀÌ»ó
  • developmental abnormality
    ¹ß´ÞÀÌ»ó
  • growth abnormality
    ¼ºÀåÀÌ»ó
  • metabolic abnormality
    ´ë»çÀÌ»ó
  • motor abnormality
    ¿îµ¿Àå¾Ö
  • nailfold capillary abnormality
    ¼ÕÅéÁÖ¸§¸ð¼¼Ç÷°üÀÌ»ó
  • positional abnormality
    À§Ä¡ÀÌ»ó
  • protonflow abnormality
    ¾çÀÚÈ帧ÀÌ»ó
  • blood glucose
    Ç÷´ç
  • glucose lactate cycle
    ±Û·çÄÚ¿À½º¶ôÆ®»êȸ·Î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • GTT= glucose tolerance test
    ´çºÎÇÏ °Ë»ç.
  • Glucose tolerance
    ³»´ç·Â(Ò±ÓØÕô)
  • glucose insulin tolerance test =GITT
    Æ÷µµ´çÀν¶¸°ºÎÇϽÃÇè.
  • glucose tolerance
    ³»´ç·Â(Ò±ÓØæ³).
  • glucose tolerance test
    ´çºÎÇϽÃÇè
  • glucose tolerance test =GTT
    ´çºÎÇϰ˻ç(ÓØÝ¶ùÃËþÞÛ).
  • abnormality
    ºñÁ¤»ó
  • abnormality by infection
    °¨¿°±âÇü
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
  • abnormality of conduction
    ÀüµµÀÌ»ó.
  • abnormality of organ
    ±â°üÀÌ»ó
  • abnormality of tissue
    Á¶Á÷ÀÌ»ó
  • growth abnormality
    ¹ßÀ°ÀÌ»ó.
  • growth abnormality
    ¼ºÀåÀÌ»ó
  • positional abnormality
    À§Ä¡ÀÌ»ó(êÈöÇì¶ßÈ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cortisone glucose tolerance test =CGTT
    ÄÚ¸£Æ¼¼Õ Æ÷µµ´ç ºÎÇϽÃÇè(¡­øã Ô¬ÓØÝ¶ùÃãËúÐ).
  • diabetes mellitus,oral glucose tolerance test
    °æ±¸´çºÎÇÏ °Ë»ç(ÌèÏ¢ÓØÝ¶ùà ËþÞÛ)
  • glucose insulin tolerance test =GITT
    Æ÷µµ´çÀν¶¸°ºÎÇϽÃÇè.
  • glucose tolerance
    ³»´ç·Â(Ò±ÓØæ³).
  • glucose tolerance test
    ´çºÎÇϽÃÇè
  • glucose tolerance test =GTT
    ´çºÎÇϰ˻ç(ÓØÝ¶ùÃËþÞÛ).
  • oral glucose tolerance test =OGTT
    °æ±¸Æ÷µµ´çºÎÇϽÃÇè.
  • abnormality
    ºñÁ¤»ó
  • abnormality by infection
    °¨¿°±âÇü
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
  • abnormality of conduction
    ÀüµµÀÌ»ó.
  • abnormality of organ
    ±â°üÀÌ»ó
  • abnormality of tissue
    Á¶Á÷ÀÌ»ó
  • autosomal abnormality
    »ó¿°»öüÀÌ»ó(¡­æøßäô÷ì¶ßÈ).
  • behavioral abnormality =b. disorder
    ÇൿÀÌ»ó(ú¼ÔÑì¶ßÈ)=ÇൿÀå¾Ö
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Abnormality by infection
    °¨¿°±âÇü
    [¿¾ ¿ë¾î] °¨¿°ºñÁ¤»ó
  • Abnormality of organ
    ±â°üÀÌ»ó
    [¿¾ ¿ë¾î] ±â°üÀÌ»ó
  • Abnormality
    ºñÁ¤»ó
    [¿¾ ¿ë¾î] ºñÁ¤»ó
  • Growth abnormality
    ¼ºÀåÀÌ»ó
    [¿¾ ¿ë¾î] ¼ºÀåÀÌ»ó
  • Abnormality of tissue
    Á¶Á÷ÀÌ»ó
    [¿¾ ¿ë¾î] Á¶Á÷ÀÌ»ó
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tolerance
    ³»¼º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glucose tolerance factor
    ±Û·çÄÚ½º ³»¼º ÀÎÀÚ(Ò±àõì×í­)
  • glucose tolerance test
    ±Û·çÄÚ½º ³»¼º °Ë»ç(Ò±àõì×í­)
  • acquired tolerance
    "ȹµæ³»¼º (üòÔðÒ±àõ), Èij»¼º (ý­Ò±àõ)"
  • adoptive tolerance
    ¾çÀÚ³»¼º(å×í­Ò±àõ)
  • adrenaline tolerance test
    ¾Æµå·¹³¯¸° ºÎÇϽÃÇè(ݶùÃãËúÐ)
  • carbohydrate tolerance test
    ´çÁú ºÎÇϽÃÇè(ÓØòõݶùÃãËúÐ)
  • cross tolerance
    ±³Â÷³»¼º(Îßó©Ò±àõ)
  • galactose tolerance test
    °¶¶ôÅ佺 ³»¼º°Ë»ç(Ò±àõËþÞÛ)
  • immunological tolerance
    ¸é¿ª ³»¼º(Øóæ¹Ò±àõ)
  • insulin tolerance test
    Àν¶¸° ³»¼º½ÃÇè(Ò±àõãËúÐ)
  • lactose tolerance test
    "¶ôÅ佺 ºÎÇϰ˻ç(ݶùÃËþÞÛ), ¶ôÅ佺³»¼º°Ë»ç(Ò±àõËþÞÛ)"
  • phenylalanine tolerance test
    Æä´Ò¾Ë¶ó´Ñ ³»¼º½ÃÇè(Ò±àõãËúÐ)
  • tolerance
    ³»¼º (Ò±àõ)
  • transferred tolerance
    ÀüÀÌ ³»¼º(ï®ì¹Ò±àõ)
  • adenosine diphosphate glucose
    ÀÌÀλê(ì£ìÝß«)¾Æµ¥³ë½Å ±Û·çÄÚ½º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glucose tolerance
    ³»´ç·Â
  • glucose
    Æ÷µµ´ç
  • tolerance
    ³»(¾à)¼º, ³»¿ë·Â, Çã¿ë, °ü¿ë
  • tolerance test
    ³»¿ë·Â°Ë»ç, ³»¿ë¼º°Ë»ç, ³»¼º°Ë»ç
  • abnormality
    ÀÌ»ó, ÀÌ»ó¼º
  • developmental abnormality
    ¹ßÀ°ÀÌ»ó
  • growth abnormality
    ¹ßÀ°ÀÌ»ó
  • proton flow abnormality
    ¾çÀÚÀ¯µ¿ÀÌ»ó
  • complex potential
    º¹ÇÕÀüÀ§
  • electrical potential
    ˟ˤ
  • electrostatic potential
    Á¤Àü±âÀü·ù
  • evoked potential
    À¯¹ßÀüÀ§
  • magnetic potential
    ÀÚ±âÆ÷ÅÙ¼È
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
MAP malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ...
SEP self-evaluation process; sensory-evoked potential; septum; somatosensory evoked potential; sperm ent...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AITT arginine insulin tolerance test; augmented insulin tolerance test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SCIWORA Spinal Cord Injury Without Radiographic Abnormality
WMA Wall motion abnormality
FSIGTT Frequently sampled intravenous glucose tolerance test
GTF Glucose Tolerance Factor
75 g Glucose Tolerance Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cortisone glucose tolerance test
    ÄÚ¸£Æ¼¼Õ Æ÷µµ´ç ºÎÇÏ ½ÃÇè
  • uridine diphosphate glucose
    ÀÌÀÎ»ê ¿ì¸®µò ±Û·çÄÚ½º
  • venous plasma blood glucose
    Á¤¸Æ Ç÷Àå Ç÷´çÄ¡, Á¤¸Æ Ç÷Àå Ç÷´ç
  • abnormality
    ÀÌ»ó¼º, ºñÁ¤»ó, ÀÌ»ó, ±âÇü
    µ¿ÀǾî=abnormity. 1. ºñÁ¤»óÀûÀÎ ¼ºÁúÀ̳ª »ç½Ç.
  • abnormality of cell interaction
    ¼¼Æ÷ »óÈ£ÀÛ¿ë ÀÌ»ó
    ¼¼Æ÷ »çÀÌ¿¡ ÀϾ´Â ÀÛ¿ëÀÌ ºñÁ¤»óÀûÀÎ °Í.
  • abnormality of organ
    ±â°ü ÀÌ»ó
    Æó, ½ÉÀå, °£Àå, ÃéÀå, ½ÅÀå µî°ú °°Àº ±â°üÀÇ Çüųª ¼ö°¡ Á¤»óÀûÀÌÁö ¾ÊÀº »óÅÂ.
  • autosomal abnormality
    »ó¿°»öü ÀÌ»ó
  • behavioral abnormality
    Çൿ ÀÌ»ó
    µ¿ÀǾî=behavioral disorder.
  • chromosome abnormality
    ¿°»öü ÀÌ»ó
  • functional abnormality
    ±â´ÉÀû ÀÌ»ó
  • hematologic abnormality
    Ç÷¾× ÀÌ»ó, Ç÷¾× Áúȯ
  • movement abnormality
    ¿îµ¿ ÀÌ»ó
  • other abnormality
    ±âŸ ÀÌ»ó
  • positional abnormality
    À§Ä¡ ÀÌ»ó
  • acquired tolerance
    ÈÄõ ³»¼º, ÈÄõ¼º ³»¼º, ȹµæ °ü¿ë
    1. Áö¼ÓÀûÀÎ ¹Ýº¹ »ç¿ë¿¡ ÀÇÇÑ ¾à¹°ÀÇ Åë»ó È¿°ú¿¡ ´ëÇÑ ³»¼ºÀÇ Áõ°¡. 2. ¸é¿ªÀûÀ¸·Î Ç׿ø ƯÀÌÀûÀÎ ¹«¹ÝÀÀ »óÅÂ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
glucose tolerance factor A water-soluble complex containing chromium needed for normal glucose tolerance.
(05 Mar 2000)
glucose tolerance test <chemical pathology, investigation> A special test where the blood glucose is measure in intervals after a glucose-rich meal is taken, a test used for diagnosing diabetes.
(27 Sep 1997)
impaired glucose tolerance Blood glucose (sugar) levels higher than normal but not high enough to be called diabetes. People with impaired glucose tolerance may or may not develop diabetes.
Other names (no longer used) for impaired glucose tolerance are borderline, subclinical, chemical, or latent diabetes.
(30 Mar 1998)
test, glucose tolerance After fasting, a specific amount (100 grams) of glucose is given by mouth, and the blood levels of this sugar are measured every hour. Normally, the blood glucose should return to normal within 2 to 2 1/2 hours. The gtt is considered a classic test of carbohydrate metabolism. It is much used in the diagnosis of diabetes. The gtt depends on a number of factors including the ability of the intestine to absorb glucose, the power of the liver to take up and store glucose, the capacity of the pancreas to produce insulin, and the amount of active insulin.
(12 Dec 1998)
abnormality 1. The state or quality of being abnormal.
2. An anomaly, deformity, malformation, impairment, or dysfunction.
(05 Mar 2000)
snowman abnormality A radiographic appearance associated with total anomalous drainage of the pulmonary venous circulation into enlarged right and anomalous left venae cavae, that produces a globular density above the heart; the silhouette suggests the figure 8.
Synonym: snowman abnormality.
(05 Mar 2000)
karyotypic abnormality Abnormality in the number form or structure of chromosomes. Particular abnormalities are associated with particular sub- types of leukaemia.
(27 Sep 1997)
figure-of-8 abnormality A radiographic appearance associated with total anomalous drainage of the pulmonary venous circulation into enlarged right and anomalous left venae cavae, that produces a globular density above the heart; the silhouette suggests the figure 8.
Synonym: snowman abnormality.
(05 Mar 2000)
acoustic tolerance The maximum sound pressure level that can be experienced without producing pain or permanent defect of hearing in a normal individual.
(05 Mar 2000)
bile acid tolerance test A sensitive test of hepatic dysfunction; following oral administration of labelled or unlabelled bile acid, the measured fractional disappearance rate or 10-minute retention is measured.
(05 Mar 2000)
galactose tolerance test A liver function test, based on the ability of the liver to convert galactose to glycogen, measured by the rate of excretion of galactose following ingestion or intravenous injection of a known amount; normally, less than 3 g appear in the urine within 5 hours after the ingestion of 40 g.
(05 Mar 2000)
radiation tolerance The ability of some cells or tissues to withstand ionizing radiation without serious injury. Tolerance depends on the species, cell type, and physical and chemical variables, including radiation-protective agents and radiation-sensitizing agents.
(12 Dec 1998)
pain tolerance The greatest intensity of painful stimulation that an individual is able to tolerate.
(05 Mar 2000)
gamma-tolerance The tolerance of a person or a piece of equipment to forces that develop as a result of acceleration or deceleration.
(05 Mar 2000)
vibration tolerance The maximum vibratory or oscillatory movements that an individual can experience and bear without pain; the limit of tolerance is a function of amplitude and frequency of the vibration and varies with the direction of application.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glucose
    Æ÷µµ´ç
  • abnormality
    ºñÁ¤»ó
  • abnormality
    ÀÌ»ó;º¯Ä¢;º´½Å;ºÒ±¸
  • tolerance
    °ü¿ë
  • frustration tolerance
    ¿å±¸ ºÒ¸¸ ³»¼º
  • tolerance
    °ü¿ë;¾Æ·®;³»¾à·Â;°øÂ÷;Çô¿ëÂ÷;¿©À¯
  • potential
    ÀáÀçÇÏ´Â
  • contact potential
    Á¢ÃË ÀüÀ§Â÷
  • electric potential
    ˟ˤ
  • magnetic potential
    ÀÚÀ§
  • market potential
    ½ÃÀåÀÇ ÀáÀç ´É·Â
  • potential
    °¡´ÉÇÑ;°¡´É¼º;ÀüÀ§ÀÇ;°¡´É¹ýÀÇ;°¡´É¼º;Àá¼¼;ÀáÀç·Â;ÀüÀ§;°¡´É¹ý 1
  • potential sovereighty
    ÀáÀç ÁÖ±Ç
  • potential transformer
    °è±â¿ëº¯¾Ð±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á